Bibliometric Analysis of Traditional Chinese Medicine in Treating Eczema

Eczema, particularly atopic dermatitis (AD), is a chronic relapsing inflammatory skin disease. While biologics and JAK inhibitors have advanced treatment, challenges remain in sustained remission and long-term safety. Traditional Chinese Medicine (TCM) may offer complementary or steroid-sparing benefits via anti-inflammatory, immunomodulatory, and barrier-repair mechanisms. This bibliometric analysis retrieved English publications from Web of Science (WOS), PubMed, and Scopus (2010-2025). After deduplication using NoteExpress and manual screening, 158 publications were included, CiteSpace with VOSviewer were used for visualization. Publications rose markedly after 2019, with China leading output. Research foci shifted from clinical efficacy to mechanisms and network pharmacology. Limitations include weak international collaboration and limited study of non-AD eczema. Future priorities include multi-center trials, mechanistic research on TCM formulas, validated outcomes (EASI, DLQI, TEWL), and expanded subtype coverage.